Skip to main content
. 2018 Feb 12;24(11):1158–1163. doi: 10.1016/j.cmi.2018.02.004

Table 3.

Viruses detected in LRTI patients and their matched controls

Organism, n/total (%) Patients with LRTI,
Matched controls
Day 1 (n = 3104)a Days 28–35 (n = 2673)a p-valueb (n = 2063)a p-valueb
Rhinoviruses 623 (20.1) 113 (4.2) <0.0001 72 (3.5) <0.0001
Influenza virus A/B 307 (9.9) 11 (0.4) <0.0001 7 (0.3) <0.0001
Coronaviruses 231 (7.4) 71 (2.7) <0.0001 29 (1.4) <0.0001
Respiratory syncytial virus 144 (4.6) 13 (0.5) <0.0001 10 (0.5) <0.0001
Human metapneumovirus 138 (4.4) 7 (0.3) <0.0001 3 (0.1) <0.0001
Parainfluenza viruses 1–4 81 (2.6) 13 (0.5) <0.0001 7 (0.3) <0.0001
Adenoviruses 41 (1.3) 42 (1.6) 0.328 23 (1.1) 0.831
Polyomavirus 69 (2.2) 82 (3.1) 0.017 52 (2.5) 0.060
Polyomavirus WU 44 (1.4) 54 (2.0) 36 (1.7)
Polyomavirus KI 27 (0.9) 28 (1.0) 17 (0.8)
Bocavirus 18 (0.6) 11 (0.4) 0.433 16 (0.8) 0.161

Abbreviations: CAP, community-acquired pneumonia; LRTI, lower respiratory tract infection.

a

Denominator varies per aetiological agent due to ‘not tested’ in max 0.6% on days 1 and 3.7% of samples on days 28–35 and missing data in controls.

b

The Generalized Estimating Equations took clustering of Day 1 and Days 28–35 samples within the same patients and clustering of Day 1 samples of patients and their matched controls into account.